INDIGO Biosciences, Inc.
The Nuclear Receptor Experts
INDIGO is a low risk investment. Its proven technology and "A" list customers are the basis for the Company's growth and profitability. With the world's largest portfolio of nuclear receptor assay kits and screening services, our product are distributed worldwide. Customers purchase INDIGO products to improve the speed, accuracy, ease, and cost efficiency of their drug discovery research. BFTP and LSGPA are seed stage investors in INDIGO.